Clinical Trials Directory

Trials / Completed

CompletedNCT02893943

Impact of Probiotics on Weight Control and Body Composition in Overweight and Obese Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to evaluate the potential of probiotics on weight management. It is hypothesized that the consumption of 1 capsule of probiotics daily will modulate the intestinal gut microbiota thereby reducing body weight and fat compared to those who do not consume probiotics. In addition, a diet supplemented with probiotics can be expected to be more beneficial than a diet without probiotic supplementation in impacting biomarkers of obesity-associated disorders including diabetes, hypertension and cardiovascular disease (CVD).

Detailed description

Overweight, obese men and women volunteers aged between 18-65 yrs with BMI greater than or equal to 25 will be recruited from the Winnipeg (Manitoba, Canada) area to participate in a two arm crossover, randomized, double-blind, placebo-controlled, free-living intervention study for 60 days per study period following obtainment of informed consent. Participants will be informed to maintain their usual diets as well as their physical activity level. After obtaining consent, participants will be randomized to receive either 1 capsule containing probiotics, or 1 capsule of placebo daily for 60 days. Compared with the probiotic capsules, the placebo contains the same carrier material and is similar in size, shape and taste.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotics
DIETARY_SUPPLEMENTPlacebo

Timeline

Start date
2017-01-01
Primary completion
2017-07-31
Completion
2018-01-31
First posted
2016-09-09
Last updated
2023-03-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02893943. Inclusion in this directory is not an endorsement.